News Archives - Page 5 of 8 - MaxWell Biosystems

MaxWell Biosystems at ISSCR2017 Annual Meeting

June 20, 2017

MaxWell Biosystems had a great time at the ISSCR2017 Annual Meeting in Boston. The conference was held on the 14th to 17th of June at the Boston Convention and Exhibition Center. The ISSCR annual meeting brought together stem cell researchers from all over the world aiming to create strong research networks and new opportunities to push forward the research about degenerative and rare diseases. One of the highlights of the meeting was the talk of Prof. Dr. Shinya Yamanaka, who received a Nobel Prize…

MaxWell Biosystems at venture leaders Life Science 2017 in Boston

June 19, 2017

Lucia Garbini

Events, News, Startup

From the 12th to the 16th of June MaxWell Biosystems and other nine Swiss Life Science startups participated in the business-boosting venture leaders Life Science program, held in Boston. It was an inspiring week, co-organized by swissnex Boston, with pitching events, company visits, and meetings with VCs and experts. Indeed, it was a great opportunity for the ten selected startups to take the first steps towards global expansion. The ten startups met medtech and biotech industry experts who gave motivating feedback on different aspects of business development. The…

MaxWell Biosystems wins Venture Kick

May 23, 2017

Marie Obien

Awards, News, Startup

MaxWell Biosystems passes the final stage of Venture Kick and wins CHF 100’000. After presenting at the final stage, MaxWell Biosystems convinced the Venture Kick jury and secured CHF 100’000, in addition to CHF 30’000 already granted in previous stages. Venture Kick supports the first steps of the realization of a business idea and awards selected start-ups with up to CHF 130’000 seed money. The final stage serves as the culmination of the year-long journey of MaxWell Biosystems with Venture Kick. The journey started last July…

MaxWell Biosystems featured in ETH News

May 23, 2017

Marie Obien

News, Startup

MaxWell Biosystems gets more media coverage. ETH Zurich News features the spin-off company MaxWell Biosystems. The article highlights the company’s core technology developed in Hierlemann Lab (D-BSSE) and the motivation to commercialize thanks to the demand of induced pluripotent stem cell boom. Link to English version >> Link to German version >>

MaxWell Biosystems at Startup Champions Seed Night

April 27, 2017

Lucia Garbini

News, Startup

MaxWell Biosystems participated at the startup presentation event “Startup Champions Seed Night” on the 26th of April in the Rolex Learning Center Forum in EPFL. The event was co-organized by EPFL Alumni, the Innogrants and venturelab. A nice audience of 400 people attended the event.

Cookie	Duration	Description
cookielawinfo-checbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.